Bipolar Research And Innovation Network - BRAIN

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2015 by Norwegian University of Science and Technology
University of Oslo
Information provided by (Responsible Party):
Norwegian University of Science and Technology Identifier:
First received: September 16, 2005
Last updated: May 12, 2015
Last verified: May 2015
To describe the broad spectrum of Bipolar Disorder patients admitted to out-patient and in-patient psychiatric departments in Norway. Include all admitted Bipolar patients both with and without co-morbid disorders.

Bipolar Disorder

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Bipolar Research And Innovation Network - BRAIN

Resource links provided by NLM:

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • characterization of bipolar disorders [ Time Frame: 15 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA
Blood samples

Estimated Enrollment: 3000
Study Start Date: January 2003
Estimated Study Completion Date: January 2020
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)
Detailed Description:

Norway is both social, genetically and culturally a homogeneous society. The health service is public and has a nearly total responsibility for psychiatric care in given catchment areas. This provides excellent opportunities to describe the frequencies and patterns of the broad spectrum of bipolar illness, including co-morbid substance use disorders, to follow the patients for several years and to do molecular genetic mapping.

Methods: Participating centers consist of outpatient clinics and hospital departments from different parts of Norway and one third-line clinic with referrals from all over Norway. Specifically trained clinicians in each center include bipolar patients systematically and perform the patient evaluation as part of their clinical duties. In addition, CT or MRI scans and EEG are performed and blood samples are collected for clinical chemistry screening and for DNA sampling.


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Secondary care clinics

Inclusion Criteria:

  • All admitted patients giving written consent to participate in the study

Exclusion Criteria:

  • Patients without competence for consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00201526

Contact: Gunnar Morken, PhD MD +47 72823034

Medical Faculty, Norwegian University of Science And Technology Recruiting
Trondheim, Norway, 7441
Contact: Gunnar Morken, MD PhD    +4772823034   
Principal Investigator: Gunnar Morken, MD PhD         
Sponsors and Collaborators
Norwegian University of Science and Technology
University of Oslo
Principal Investigator: Gunnar Morken, PhD MD Norwegian University of Science and Technology
  More Information

No publications provided

Responsible Party: Norwegian University of Science and Technology Identifier: NCT00201526     History of Changes
Other Study ID Numbers: BRAIN-04
Study First Received: September 16, 2005
Last Updated: May 12, 2015
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Bipolar Disorder

Additional relevant MeSH terms:
Bipolar Disorder
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders processed this record on November 25, 2015